KLAS survey: 45% pondering CVIS consolidation

Candace Stuart | | Cardiovascular Business | CVIS

One third of cardiology departments have consolidated their cardiovascular information system (CVIS) vendors and 45 percent plan to do so, according to a recent survey.

KLAS research surveyed providers who use at least two structured reporting modules about their consolidation plans. The survey addressed topics such as core reporting areas, workflow functionality, remote access and consolidation of structured reporting.

A total of 117 providers answered the question about plans to consolidate their cardiology solutions. Of those, 33 percent had already consolidated; 22 percent had no plans to consolidate; 21 percent planned to consolidate and would consider their current vendor; 18 percent planned to consolidate but would not consider their current vendor; and 6 percent planned to consolidate but were up in the air about vendors.

Based on survey responses from 392 providers, the KLAS report named Merge Healthcare the leader for overall performance. Other vendors included in the analysis were Philips, Siemens, Agfa HealthCare, Digisonics, Epic, Fujifilm, GE Healthcare, INFINITT, LUMEDX, McKesson and Wolters Kluwer.

Find more CVIS and cardiology informatics news

Candace Stuart, Contributor

Related Content

GE HealthCare recalls legacy cardiology information systems due to security risk
Alabama security breach exposes personal information of cardiologists, heart patients
SCCT aims to provide common language for CCTA use with updated guidance
Best in KLAS 2024: New rankings for cardiovascular information systems, hemodynamic solutions
PHOTO GALLERY: ACC.23 in New Orleans
KLAS 2023 rankings for cardiovascular information systems and hemodynamic solutions

Around the web

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

Radiology Business
U.S. iodine contrast supply may not be subject to proposed 25% tariffs

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.